Hartford Investment Management CO Eli Lilly & CO Transaction History

Hartford Investment Management CO

$2.99 Billion
Q3 2024

A detailed history of Hartford Investment Management CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Hartford Investment Management CO holds 49,650 shares of LLY stock, worth $39.5 Million. This represents 1.47% of its overall portfolio holdings.

Number of Shares

49,650

Previous 51,146 2.92%

Holding current value

$39.5 Million

Previous $46.3 Million 5.01%

% of portfolio

1.47%

Previous 1.61%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$772.14 - $960.02 $1.16 Million - $1.44 Million	-1,496 Reduced 2.92%	49,650 $44 Million
Q2 2024 Aug 01, 2024	SELL	$724.87 - $909.04 $279,074 - $349,980	-385 Reduced 0.75%	51,146 $46.3 Million
Q1 2024 Apr 17, 2024	SELL	$592.2 - $792.28 $1.3 Million - $1.73 Million	-2,189 Reduced 4.07%	51,531 $40.1 Million
Q4 2023 Jan 23, 2024	SELL	$525.19 - $619.13 $412,274 - $486,017	-785 Reduced 1.44%	53,720 $31.3 Million
Q3 2023 Oct 16, 2023	SELL	$434.7 - $599.3 $328,198 - $452,471	-755 Reduced 1.37%	54,505 $29.3 Million
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $3.91 Million - $5.22 Million	-11,134 Reduced 16.77%	55,260 $25.9 Million
Q1 2023 May 09, 2023	SELL	$310.63 - $364.82 $2.52 Million - $2.96 Million	-8,117 Reduced 10.89%	66,394 $22.8 Million
Q4 2022 Jan 20, 2023	SELL	$321.55 - $374.67 $112,864 - $131,509	-351 Reduced 0.47%	74,511 $27.3 Million
Q3 2022 Nov 02, 2022	SELL	$296.48 - $337.87 $204,867 - $233,468	-691 Reduced 0.91%	74,862 $24.2 Million
Q2 2022 Jul 22, 2022	BUY	$278.73 - $327.27 $133,232 - $156,435	478 Added 0.64%	75,553 $24.5 Million
Q1 2022 Apr 20, 2022	SELL	$234.69 - $291.66 $1.3 Million - $1.62 Million	-5,557 Reduced 6.89%	75,075 $21.5 Million
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $1.45 Million - $1.8 Million	6,456 Added 8.7%	80,632 $22.3 Million
Q3 2021 Nov 01, 2021	SELL	$221.6 - $272.71 $3.05 Million - $3.75 Million	-13,755 Reduced 15.64%	74,176 $17.1 Million
Q2 2021 Jul 29, 2021	SELL	$180.55 - $233.54 $345,572 - $446,995	-1,914 Reduced 2.13%	87,931 $20.2 Million
Q1 2021 Apr 21, 2021	SELL	$164.32 - $212.72 $523,030 - $677,087	-3,183 Reduced 3.42%	89,845 $16.8 Million
Q4 2020 Feb 01, 2021	BUY	$130.46 - $172.63 $1.08 Million - $1.43 Million	8,273 Added 9.76%	93,028 $15.7 Million
Q3 2020 Oct 29, 2020	SELL	$146.22 - $169.13 $1.23 Million - $1.42 Million	-8,424 Reduced 9.04%	84,755 $12.5 Million
Q2 2020 Aug 04, 2020	SELL	$136.42 - $164.18 $1.24 Million - $1.49 Million	-9,061 Reduced 8.86%	93,179 $15.3 Million
Q1 2020 Apr 24, 2020	BUY	$119.05 - $147.35 $163,217 - $202,016	1,371 Added 1.36%	102,240 $14.2 Million
Q4 2019 Jan 29, 2020	SELL	$106.92 - $132.43 $283,979 - $351,734	-2,656 Reduced 2.57%	100,869 $13.3 Million
Q3 2019 Oct 28, 2019	SELL	$106.79 - $116.16 $425,771 - $463,129	-3,987 Reduced 3.71%	103,525 $11.6 Million
Q2 2019 Jul 25, 2019	BUY	$110.79 - $129.32 $90,958 - $106,171	821 Added 0.77%	107,512 $11.9 Million
Q1 2019 Apr 29, 2019	SELL	$111.31 - $131.02 $1.44 Million - $1.69 Million	-12,914 Reduced 10.8%	106,691 $13.8 Million
Q4 2018 Feb 04, 2019	BUY	$105.9 - $118.64 $36,111 - $40,456	341 Added 0.29%	119,605 $13.8 Million
Q3 2018 Nov 08, 2018	BUY	$85.86 - $107.31 $57,182 - $71,468	666 Added 0.56%	119,264 $12.8 Million
Q2 2018 Jul 19, 2018	SELL	$75.7 - $86.88 $5.66 Million - $6.49 Million	-74,713 Reduced 38.65%	118,598 $10.1 Million
Q1 2018 Apr 24, 2018	SELL	$74.21 - $87.6 $1.28 Million - $1.52 Million	-17,295 Reduced 8.21%	193,311 $15 Million
Q4 2017 Feb 12, 2018	SELL	$81.94 - $87.89 $645,523 - $692,397	-7,878 Reduced 3.61%	210,606 $17.8 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $16.8 Million - $18.7 Million	218,484	218,484 $18.7 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.

Account

Hartford Investment Management CO Eli Lilly & CO Transaction History